시장보고서
상품코드
1611041

정맥내 카테터 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Intravenous Catheters Market Size, Share & Trends Analysis Report By Type (Peripheral Catheters, Midline Peripheral Catheters, Central Venous Catheters), By End-use (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2030

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

정맥내 카테터 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 정맥내 카테터 세계 시장 규모는 2025-2030년 동안 CAGR 6.0%를 기록하여 2030년에는 130억 7,000만 달러에 달할 것으로 추정됩니다. 무위험 IV 카테터 제품에 대한 R&D 투자 증가, 일회용 IV 카테터에 대한 수요 증가, 항균 IV 카테터에 대한 수요 증가가 산업 성장을 가속화하는 주요 촉진요인입니다. 신제품 출시, 업계 주요 기업 간 인수합병 증가, 연령대별 특정 환자군에 특화된 IV 카테터에 대한 수요 증가가 시장 성장의 주요 요인으로 작용할 것으로 예상됩니다.

업계의 주요 진입자들은 제품 포트폴리오를 강화하는 새로운 IV 카테터 장치 제조에 참여하고 있습니다. 신제품 출시는 시장을 변화시키고, 새로운 전략을 제공하고, 환자 치료의 미충족 수요를 충족시키기 위해 필수적입니다. 환자 결과를 개선하고 의료 절차를 간소화하는 것을 목표로 이러한 혁신적인 제품은 최첨단 기술, 강화된 안전 조치 및 기능 강화가 자주 결합되어 있습니다.

2023년 11월, BD는 일체형 카테터에 적합한 새로운 무침 채혈 기기를 출시했습니다. 미국 FDA는 PIVO(Peripherally Inserted Vascular Output device) 무침 채혈 기기에 510(k) 승인을 부여했습니다. PIVO는 NearPortTM 정맥 접근이 가능한 NexivaTM 폐쇄형 정맥내 카테터 시스템과 같은 일체형 및 긴 말초 정맥내 카테터와 호환되는 최초이자 유일한 무침 채혈 기기로 설계 및 개발됐습니다. 이는 2017년부터 기존의 짧은 말초정맥내 카테터에서 제공되고 있는 PIVO 기능을 강화한 것입니다.

정맥내 카테터 시장 보고서 하이라이트

  • 유형별로는 말초 카테터 부문이 비용 효율성, 삽입 용이성, 낮은 합병증 위험으로 인해 2024년 41.1%의 점유율을 차지하며 시장을 장악했습니다.
  • 2024년에는 병원 약국 부문이 가장 큰 매출 점유율을 차지했습니다. 수술, 치료 및 시술을 위해 입원하는 환자 수가 증가함에 따라 가까운 장래에 정맥내 카테터에 대한 수요가 증가할 것으로 예상됩니다.
  • 북미는 신경질환, 감염성 질환, 비뇨기과 질환의 높은 발병률로 인해 2024년 34.8%의 가장 높은 매출 점유율을 기록하며 지역 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 정맥내 카테터 시장 변수, 동향, 범위

  • 시장 계통 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 산업 과제
  • 정맥내 카테터 시장 분석 툴
    • Porters 분석
    • PESTEL 분석
  • 문제점 분석

제4장 정맥내 카테터 시장 : 유형별, 추정·동향 분석

  • 부문 대시보드
  • 정맥내 카테터 시장 : 유형 변동 분석, 2024년과 2030년
  • 말초 카테터
  • 정중선 말초 카테터
  • 중심정맥 카테터

제5장 정맥내 카테터 시장 : 최종 용도별, 추정·동향 분석

  • 부문 대시보드
  • 정맥내 카테터 시장 : 최종 용도 변동 분석, 2024년과 2030년
  • 병원 약국
  • 소매 약국
  • 기타

제6장 정맥내 카테터 시장 : 지역별, 추정·동향 분석

  • 정맥내 카테터 시장 점유율, 지역별, 2024년과 2030년
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 노르웨이
    • 덴마크
    • 스웨덴
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 한국
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제7장 경쟁 구도

  • 기업 분류
  • 기업의 시장 포지셔닝
  • 기업 히트맵 분석
  • 기업 개요
    • BD
    • Boston Scientific Corporation
    • B Braun SE
    • Mediplus India Ltd
    • Sterimed Group
    • Medilivescare Manufacturing Pvt. Ltd.
    • Angiplast Pvt Ltd.
    • Teleflex Incorporated
    • Terumo Medical Corporation
    • Nipro Europe Group Companies
    • Cook
    • ICU Medical, Inc
    • TuCann Medical
ksm 25.01.03

Intravenous Catheters Market Growth & Trends:

The global intravenous catheters market size is estimated to reach USD 13.07 billion by 2030, registering a CAGR of 6.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising R&D investments for risk free IV catheter products, increasing demand for disposable IV catheters, and increasing demand for antimicrobial IV catheters are the major driving factors accelerating the industry growth. Novel product launch, increasing mergers and acquisition among the industry key players, and the rising demand for specialized IV catheters for specific patient population based on age group are key contributors to the market growth.

The industry key players are involved in manufacturing novel IV catheter devices which also enhance the product portfolio. Launching new products is essential for transforming the market, offering novel strategies, and addressing unmet needs in patient care. With the goal of improving patient outcomes and streamlining healthcare procedures, these innovative products frequently combine cutting-edge technologies, increased safety measures, and enhanced functionality.

In November 2023, BD launched new needle-free blood collection equipment that is suitable with integrated catheters. The U.S. FDA has granted the PIVO (Peripherally Inserted Vascular Output device) Needle-Free Blood Collection device received 510(k) approval. The design developments of the devices enable it to be the first and only needle-free blood collection device that is compatible with both integrated and long peripheral intravenous catheters, such as the NexivaTM closed intravenous catheter system with NearPortTM intravenous access. This enhances the PIVO functionality that has been provided since 2017 with conventional short peripheral IV catheters.

Intravenous Catheters Market Report Highlights:

  • Based on type, peripheral catheters segment dominated the market in 2024 with a share of 41.1% owing to the cost-effectiveness, ease of insertion and low risk of complications
  • The hospital pharmacies segment held the largest revenue share in 2024. The increasing number of patients being admitted to hospitals due to surgeries, therapies, and treatments is expected to increase the demand for intravenous catheters in the near future
  • North America dominated the regional market with the highest revenue share of 34.8% in 2024 owing to high incidence rate of neurological disease, infections, and urological diseases in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. Methodology
  • 1.5. Research Scope and Assumptions
  • 1.6. Market Formulation & Validation
  • 1.7. Country Based Segment Share Calculation
  • 1.8. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Intravenous Catheters Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
    • 3.2.2. Market Restraints Analysis
    • 3.2.3. Industry Challenges
  • 3.3. Intravenous Catheters Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
  • 3.4. Pain Point Analysis

Chapter 4. Intravenous Catheters Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Intravenous Catheters Market: Type Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Peripheral Catheters
    • 4.3.1. Peripheral Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Midline Peripheral Catheters
    • 4.4.1. Midline Peripheral Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Central Venous Catheters
    • 4.5.1. Central Venous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Intravenous Catheters Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Intravenous Catheters Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Hospital Pharmacies
    • 5.3.1. Hospital Pharmacies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Retail Pharmacies
    • 5.4.1. Retail Pharmacies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Intravenous Catheters Market: Regional Estimates & Trend Analysis

  • 6.1. Intravenous Catheters Market Share, By Region, 2024 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Norway
      • 6.3.7.1. Norway Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Denmark
      • 6.3.8.1. Denmark Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Sweden
      • 6.3.9.1. Sweden Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Intravenous Catheters Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Company Market Positioning
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. BD
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Boston Scientific Corporation
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. B Braun SE
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Mediplus India Ltd
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Sterimed Group
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Medilivescare Manufacturing Pvt. Ltd.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Angiplast Pvt Ltd.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Teleflex Incorporated
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Terumo Medical Corporation
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Nipro Europe Group Companies
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. Cook
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. ICU Medical, Inc
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. TuCann Medical
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제